𩺠å
§ç§å°ç§èåç
ð äžé éé»
- 22E: afamelanotide for EPP (FDA 2019)
- Taiwan: HCV â PCT, dengue endemic è£
- DAA HCV æ²»çåŸ PCT æ¹å
ð Pearls (6)
- Afamelanotide = α-MSH analog â â eumelanin â photoprotect EPP
- PCT + HCV â DAA æ²»ç = éšå PCT remission
- Voriconazole long-term photosensitivity + skin cancer 颚éª
- Patch test + photopatch test for photoallergic
- Phototherapy for vit D / psoriasis caveats
- Sunscreen with iron oxides for visible light protection (melasma, lupus)
ð Taiwan
- HCV é« â PCT prevalence
- å¥ä¿ DAA HCV
- Afamelanotide èªè²»
ð å
§å°éé»
- UVA/UVB æ©èœ
- 5 é¡å
åæ
- Porphyria 5 type
- Drug-induced å°æ
- Afamelanotide (22E)
â ïž AI èçš¿ã